Lee, Yen-Chieh <br/><br/>
Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.  [electronic resource] 

 -  International journal of cardiology  Feb 2017 
 - 1007-1014 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2016.11.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acarbose--adverse effects<br/>Administration, Oral<br/>Age Factors<br/>Aged<br/>Carbamates--adverse effects<br/>Cohort Studies<br/>Confidence Intervals<br/>Databases, Factual<br/>Diabetes Mellitus, Type 2--diagnosis<br/>Female<br/>Follow-Up Studies<br/>Heart Failure--etiology<br/>Hospital Mortality<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Incidence<br/>Male<br/>Middle Aged<br/>Piperidines--adverse effects<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Assessment<br/>Sex Factors<br/>Sulfonylurea Compounds--adverse effects<br/>Survival Rate<br/>Taiwan